Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...

Common side effects are mild burning or stinging when ... The Food and Drug Administration (FDA) has approved the biologic drug dupilumab (Dupixent). Doctors prescribe it for people with moderate ...

Dupixent (dupilumab) achieved a five-fold greater ... which can have serious long-term side effects, said Sanofi and Regeneron. In the 106-patient study, 41% of Dupixent-treated patients achieved ...

Beyond the personalization of medicine, the treatments are sure to be far more effective and have fewer side effects as they are now empowered ... in managing eosinophilic esophagitis. Dupixent, or ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Shares acquired will be canceled and will have an accretive effect to Sanofi's earning per ... On the regulatory side, we've made substantial progress with 21 acceptances of our regulatory ...

The treatment effect was consistent across subgroups and safety data revealed no serious side effect signals ... dollar blockbuster Dupixent (dupilumab), which is approved across several ...

Dupixent (dupilumab) was the first biologic treatment approved for ... Many people have to stop taking these medications because they can cause significant side effects. Biologics require less ...

Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT ... Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are ...

Compared to dupilumab, which targets only IL-4Rα and has limited ... long-term clinical studies are necessary to fully assess the safety, efficacy, and potential side effects of nanobody based asthma ...

Fewer than 10% of children or adolescents with peanut allergy passed a desnsitiaztion food challenge after receiving dupilumab for 24 weeks. Image: Adobe Stock “The impact of the findings for ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...